Search Results | Cancer Research | American Association for Cancer Research

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Abstract 2496: Preclinical testing of a novel anti-angiogenic vaccine targeting human VEGF

Madelon Q. Wentink, Peter Timmerman, Hans J. van der Vliet, Tanja D. de Gruijl, Henk M.W. Verheul, Arjan W. Griffioen

Cancer Res (2015) 75 (15_Supplement): 2496.

DOI: https://doi.org/10.1158/1538-7445.AM2015-2496

Published: 01 August 2015

View article

Journal Articles

Abstract 2989: High-dose, intermittent sunitinib as an alternative treatment strategy

Maria Rovithi, Richard R. de Haas, Richard J. Honeywell, Johannes Voortman, Arjan W. Griffioen, Mariette Labots, Anne Marije Luik, Godefridus J. Peters, Henk J. Broxterman, Henk M.w. Verheul

Cancer Res (2014) 74 (19_Supplement): 2989.

DOI: https://doi.org/10.1158/1538-7445.AM2014-2989

Published: 01 October 2014

View article

Journal Articles

Abstract 908: Development of a cell proliferation assay to be used as a read-out system for determining the in vivo potency of bevacizumab in neutralizing the biological activity of VEGF in cancer patients

Madelon Q. Wentink, Henk J. Broxterman, Tanja D. de Gruijl, Roberto Pili, Hans J. van der Vliet, Arjan W. Griffioen, Henk M.W. Verheul

Cancer Res (2014) 74 (19_Supplement): 908.

DOI: https://doi.org/10.1158/1538-7445.AM2014-908

Published: 01 October 2014

View article

Journal Articles

Abstract 1586: Improving the radio-sensitizing effect of sunitinib by drug-specific scheduling.

Esther A. Kleibeuker, Kitty C. Castricum, Jaap van den Berg, Richard Honeywell, Arjan W. Griffioen, Ben J. Slotman, Henk M. Verheul, Victor L. Thijssen

Cancer Res (2013) 73 (8_Supplement): 1586.

DOI: https://doi.org/10.1158/1538-7445.AM2013-1586

Published: 15 April 2013

View article

Journal Articles

Abstract 1613: In vitro acquired tumor cell resistance to sunitinib contributes to an in vivo resistant phenotype.

Kristy J. Gotink, Roberto Pili, Richard J. Honeywell, Arjan W. Griffioen, Godefridus J. Peters, Henk J. Broxterman, Henk MW Verheul

Cancer Res (2013) 73 (8_Supplement): 1613.

DOI: https://doi.org/10.1158/1538-7445.AM2013-1613

Published: 15 April 2013

View article

Journal Articles

Abstract 38: Galectin-9D5 is a prognostic marker in early stage non-small cell lung cancer.

Victor L. Thijssen, Iris A. Schulkens, Roy Heusschen, Vivian van den Boogaart, Robert-Jan van Suylen, Thang V. Pham, Anne-Marie C. Dingemans, Arjan W. Griffioen

Cancer Res (2013) 73 (8_Supplement): 38.

DOI: https://doi.org/10.1158/1538-7445.AM2013-38

Published: 15 April 2013

View article

Journal Articles

Abstract A12: Identification of microRNA-based therapeutic candidates using a unique lentiviral microRNA overexpression library

Cancer Res (2012) 72 (2_Supplement): A12.

DOI: https://doi.org/10.1158/1538-7445.NONRNA12-A12

Published: 03 April 2013

View article

Journal Articles

Abstract 1112: Identification of microRNA-based therapeutic candidates using a unique lentiviral microRNA overexpression library

Cancer Res (2012) 72 (8_Supplement): 1112.

DOI: https://doi.org/10.1158/1538-7445.AM2012-1112

Published: 15 April 2012

View article

Journal Articles

Abstract 3490: Identification and characterization of novel galectin-9 splice variants in endothelial cells

Roy Heusschen, Martijn de Bree, Arjan W. Griffioen, Victor Ljl Thijssen

Cancer Res (2011) 71 (8_Supplement): 3490.

DOI: https://doi.org/10.1158/1538-7445.AM2011-3490

Published: 15 April 2011

View article

Journal Articles

Abstract 5158: Plastic tumor cells engaged in vasculogenic mimicry produce PDGF-B and attract structural support

Yvette WJ Paulis, Joost J. van den Oord, Vivianne CG Tjan-Heijnen, Arjan W. Griffioen

Cancer Res (2011) 71 (8_Supplement): 5158.

DOI: https://doi.org/10.1158/1538-7445.AM2011-5158

Published: 15 April 2011

View article

Journal Articles

Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

Victor L. Thijssen, Batya Barkan, Hiroki Shoji, Ingrid M. Aries, Véronique Mathieu, Louise Deltour, Tilman M. Hackeng, Robert Kiss, Yoel Kloog, Françoise Poirier, Arjan W. Griffioen

Cancer Res (2010) 70 (15): 6216–6224.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-4150

Published: 28 July 2010

View article

Includes: Supplementary data

Journal Articles

ADAMTS1 Contributes to the Acquisition of an Endothelial-like Phenotype in Plastic Tumor Cells

Carmen Casal, Antoni Xavier Torres-Collado, María del Carmen Plaza-Calonge, Estefanía Martino-Echarri, Santiago Ramón y Cajal, Federico Rojo, Arjan W. Griffioen, Juan Carlos Rodríguez-Manzaneque

Cancer Res (2010) 70 (11): 4676–4686.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-4197

Published: 01 June 2010

View article

Includes: Supplementary data

Journal Articles

Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells

Debby M.E.I. Hellebrekers, Veerle Melotte, Emmanuelle Viré, Elise Langenkamp, Grietje Molema, François Fuks, James G. Herman, Wim Van Criekinge, Arjan W. Griffioen, Manon van Engeland

Cancer Res (2007) 67 (9): 4138–4148.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-3032

Published: 04 May 2007

View article

Includes: Supplementary data

Journal Articles

Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications

Debby M.E.I. Hellebrekers, Karolien Castermans, Emmanuelle Viré, Ruud P.M. Dings, Nicole T.H. Hoebers, Kevin H. Mayo, Mirjam G.A. oude Egbrink, Grietje Molema, François Fuks, Manon van Engeland, Arjan W. Griffioen

Cancer Res (2006) 66 (22): 10770–10777.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-1609

Published: 15 November 2006

View article

Includes: Supplementary data

Journal Articles

Angiostatic compounds stimulate tumor immunity.

Karolien Castermans, Ruud P. Dings, Loes I. Van Eijk, Mirjam G. Oude Egbrink, Kevin H. Mayo, Arjan W. Griffioen

Cancer Res (2006) 66 (8_Supplement): 1341.

Published: 15 April 2006

View article

Journal Articles

Development of anti-angiogenic, anti-tumor peptidomimetics of anginex

Ruud P M Dings, Hanke Heun, Tom R. Hoye, Arjan W. Griffioen, Kevin H. Mayo

Cancer Res (2006) 66 (8_Supplement): 225.

Published: 15 April 2006

View article

Journal Articles

Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia

Daisy W.J. van der Schaft, Femke Hillen, Patrick Pauwels, Dawn A. Kirschmann, Karolien Castermans, Mirjam G.A. oude Egbrink, Maxine G.B. Tran, Rafael Sciot, Esther Hauben, Pancras C.W. Hogendoorn, Olivier Delattre, Patrick H. Maxwell, Mary J.C. Hendrix, Arjan W. Griffioen

Cancer Res (2005) 65 (24): 11520–11528.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-2468

Published: 15 December 2005

View article

Journal Articles

Epigenetic regulation of angiogenesis: DNA methyltransferase- and histone deacetylase inhibitors have angiostatic activity

Debby M. Hellebrekers, Kam-Wing Jair, Sayaka Eguchi, Nicole T. H. Hoebers, Emmanuelle Viré, Mario Fraga, Francois Fuks, Manel Esteller, Stephen B. Baylin, Manon Van Engeland, Arjan W. Griffioen

Cancer Res (2005) 65 (9_Supplement): 425.

Published: 01 May 2005

View article

Journal Articles

Non-peptide topomimetic of anginex as a potent anti-angiogenic, anti-tumor agent

Ruud P. M. Dings, Xuemei Chen, Victor L. Thijssen, Loes I. Van Eijk, Robert J. Griffin, Tom R. Hoye, Arjan W. Griffioen, Kevin H. Mayo

Cancer Res (2005) 65 (9_Supplement): 1372.

Published: 01 May 2005

View article

Journal Articles

The transcriptional profile of tumor endothelial cells; sequential stages of angiogenesis and implications for anticancer therapy.

Judy R. Van Beijnum, Edith Van der Linden, Arjan W. Griffioen

Cancer Res (2004) 64 (7_Supplement): 752.

Published: 01 April 2004

View article

NARROW

Abstract 2496: Preclinical testing of a novel anti-angiogenic vaccine targeting human VEGF

Abstract 2989: High-dose, intermittent sunitinib as an alternative treatment strategy

Abstract 908: Development of a cell proliferation assay to be used as a read-out system for determining the in vivo potency of bevacizumab in neutralizing the biological activity of VEGF in cancer patients

Abstract 1586: Improving the radio-sensitizing effect of sunitinib by drug-specific scheduling.

Abstract 1613: In vitro acquired tumor cell resistance to sunitinib contributes to an in vivo resistant phenotype.

Abstract 38: Galectin-9D5 is a prognostic marker in early stage non-small cell lung cancer.

Abstract A12: Identification of microRNA-based therapeutic candidates using a unique lentiviral microRNA overexpression library

Abstract 1112: Identification of microRNA-based therapeutic candidates using a unique lentiviral microRNA overexpression library

Abstract 3490: Identification and characterization of novel galectin-9 splice variants in endothelial cells

Abstract 5158: Plastic tumor cells engaged in vasculogenic mimicry produce PDGF-B and attract structural support

Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

ADAMTS1 Contributes to the Acquisition of an Endothelial-like Phenotype in Plastic Tumor Cells

Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells

Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications

Angiostatic compounds stimulate tumor immunity.

Development of anti-angiogenic, anti-tumor peptidomimetics of anginex

Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia

Epigenetic regulation of angiogenesis: DNA methyltransferase- and histone deacetylase inhibitors have angiostatic activity

Non-peptide topomimetic of anginex as a potent anti-angiogenic, anti-tumor agent

The transcriptional profile of tumor endothelial cells; sequential stages of angiogenesis and implications for anticancer therapy.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only